GSK Generic Paxil Suicide Case Won’t Get Supreme Court Review

The U.S. Supreme Court declined May 28 to review a federal appeals court decision that threw out a $3 million verdict to the widow of an attorney who committed suicide while taking a generic version of GlaxoSmithKline LLC’s Paxil.

A jury awarded the damages to Wendy Dolin, widow of Stewart Dolin. She argued that GSK, which created the warning that the generic drugmaker was required to use, failed to warn about the risk of suicide in adult patients.

But the U.S. Court of Appeals for the Seventh Circuit said the claims are preempted because GSK couldn’t have changed Paxil’s warning ...